Your session is about to expire
← Back to Search
Study Summary
This trial is being conducted to see if a new medication called AXS-05 is effective in preventing the return of depressive symptoms in people with major depressive disorder. The study will compare AXS-05
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 3 trial • 327 Patients • NCT04019704Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Am I eligible to be a part of this research trial?
"To be eligible for inclusion in this clinical trial, individuals must have a diagnosis of depression and fall within the age range from 18 to 65. The study aims to enroll approximately 316 participants."
Is the recruitment phase for this medical study currently ongoing?
"Indeed, the data available on clinicaltrials.gov indicates that this study is actively seeking eligible participants. The trial was initially posted on December 27th, 2023 and recently updated on January 16th, 2024. A total of 316 patients will be enrolled across a network of 32 locations."
What is the current number of participants being recruited for this clinical study?
"Indeed, the details provided on clinicaltrials.gov indicate that this investigation is currently actively seeking individuals to participate. The trial was initially made available for viewing on December 27th, 2023 and its most recent update occurred on January 16th, 2024. To fulfill the study's requirements, a total of 316 participants are being sought from a network of 32 sites."
Are individuals who are 18 years of age or older eligible to participate in this clinical trial?
"To be eligible for this research study, participants must meet the age criteria of being at least 18 years old but no older than 65 years."
At how many different sites is this medical study currently being administered?
"Currently, this clinical trial is accepting participants at 32 different research sites. These sites are spread across various locations including Edmond, Atlanta, Lafayette, and several others. To minimize travel obligations for potential participants, it would be advantageous to select the nearest site based on proximity."
Has the Food and Drug Administration granted approval for the use of AXS-05 in medical practice?
"AXS-05 has been assigned a safety rating of 3 by our team at Power. This designation is based on the fact that the trial being conducted is in Phase 4, indicating that this treatment has already received approval."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger